Kwan Ju Lee1, Yun Jung Cho, Jeong Goo Kim, Dong Ho Lee. 1. Department of Surgery, College of Medicine, The Catholic University of Korea, Daejeon St. Mary's Hospital, 520-2, Daeheung-dong, Jung-gu, Daejeon, South Korea.
Abstract
BACKGROUND: When surgeons decide to perform lobectomy as the treatment of papillary thyroid carcinomas (PTCs), they must consider the possibility of contralateral cancer. We wanted to determine the incidence of bilateral PTCs (bPTCs) and analyze their characteristics. We also wanted to determine how many patients with bPTC were missed preoperatively. METHODS: From January 2007 to May 2011, a total of 466 patients with PTC who were treated by total thyroidectomy at a single institution were enrolled. Patients were divided into two groups based on bilaterality. The patients with bPTCs were further investigated regarding the preoperative presence of the contralateral tumor. RESULTS: Bilaterality was seen in 29.8 % of PTC patients. In all, 36.8 % of PTCs ≥ 1 cm, and 25.7 % were papillary thyroid microcarcinomas (PTMCs). The presence of PTC in the contralateral lobe was missed in 15.8 % of bPTCs and in 21.3 % of bPTMCs. The rates of preoperatively nondetected contralateral cancer were 4.7 and 5.5 % for PTCs and PTMCs, respectively. Tumor size and multifocality were factors associated with bilaterality (p = 0.014 and p < 0.001, respectively). CONCLUSIONS: Bilaterality is found more frequently when the tumor is large. Multifocality also can help predict the possibility of bilaterality. Therefore, total thyroidectomy may be necessary for patients with a multifocal or large tumor. It should be noted that the presence of a contralateral cancer is missed in 4.7 and 5.5 % of patients with preoperatively diagnosed unilateral PTC and PTMC, respectively.
BACKGROUND: When surgeons decide to perform lobectomy as the treatment of papillary thyroid carcinomas (PTCs), they must consider the possibility of contralateral cancer. We wanted to determine the incidence of bilateral PTCs (bPTCs) and analyze their characteristics. We also wanted to determine how many patients with bPTC were missed preoperatively. METHODS: From January 2007 to May 2011, a total of 466 patients with PTC who were treated by total thyroidectomy at a single institution were enrolled. Patients were divided into two groups based on bilaterality. The patients with bPTCs were further investigated regarding the preoperative presence of the contralateral tumor. RESULTS: Bilaterality was seen in 29.8 % of PTC patients. In all, 36.8 % of PTCs ≥ 1 cm, and 25.7 % were papillary thyroid microcarcinomas (PTMCs). The presence of PTC in the contralateral lobe was missed in 15.8 % of bPTCs and in 21.3 % of bPTMCs. The rates of preoperatively nondetected contralateral cancer were 4.7 and 5.5 % for PTCs and PTMCs, respectively. Tumor size and multifocality were factors associated with bilaterality (p = 0.014 and p < 0.001, respectively). CONCLUSIONS: Bilaterality is found more frequently when the tumor is large. Multifocality also can help predict the possibility of bilaterality. Therefore, total thyroidectomy may be necessary for patients with a multifocal or large tumor. It should be noted that the presence of a contralateral cancer is missed in 4.7 and 5.5 % of patients with preoperatively diagnosed unilateral PTC and PTMC, respectively.
Authors: Haggi Mazeh; Yacov Samet; David Hochstein; Ido Mizrahi; Ilana Ariel; Ahmed Eid; Herbert R Freund Journal: Am J Surg Date: 2010-09-23 Impact factor: 2.565
Authors: David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle Journal: Thyroid Date: 2009-11 Impact factor: 6.568
Authors: F Pacini; R Elisei; M Capezzone; P Miccoli; E Molinaro; F Basolo; L Agate; V Bottici; M Raffaelli; A Pinchera Journal: Thyroid Date: 2001-09 Impact factor: 6.568
Authors: E Baudin; J P Travagli; J Ropers; F Mancusi; G Bruno-Bossio; B Caillou; A F Cailleux; J D Lumbroso; C Parmentier; M Schlumberger Journal: Cancer Date: 1998-08-01 Impact factor: 6.860
Authors: Paolo Miccoli; Michele N Minuto; Clara Ugolini; Erica Panicucci; Piero Berti; Marco Massi; Fulvio Basolo Journal: World J Surg Date: 2007-05 Impact factor: 3.352
Authors: Giovanni Conzo; Nicola Avenia; Giuseppe Bellastella; Giancarlo Candela; Annamaria de Bellis; Katherine Esposito; Daniela Pasquali; Andrea Polistena; Luigi Santini; Antonio Agostino Sinisi Journal: Endocrine Date: 2014-04-10 Impact factor: 3.633
Authors: Liu Yihao; Li Shuo; Xi Pu; Wang Zipeng; Sun Hanlin; Chang Qungang; Wang Yongfei; Yin Detao Journal: Int J Endocrinol Date: 2022-06-28 Impact factor: 2.803
Authors: Lutske Lodewijk; Wouter P Kluijfhout; Jakob W Kist; Inge Stegeman; John T M Plukker; Els J Nieveen van Dijkum; H Jaap Bonjer; Nicole D Bouvy; Abbey Schepers; Johannes H W de Wilt; Romana T Netea-Maier; Jos A van der Hage; Jacobus W A Burger; Gavin Ho; Wayne S Lee; Wen T Shen; Anna Aronova; Rasa Zarnegar; Cassandre Benay; Elliot J Mitmaker; Mark S Sywak; Ahmad M Aniss; Schelto Kruijff; Benjamin James; Raymon H Grogan; Laurent Brunaud; Guillaume Hoch; Chiara Pandolfi; Daniel T Ruan; Michael D Jones; Marlon A Guerrero; Gerlof D Valk; Inne H M Borel Rinkes; Menno R Vriens Journal: Langenbecks Arch Surg Date: 2016-03-24 Impact factor: 3.445